Nanomedicine for Combination Therapy Based on Cell Therapy and Nanomedicine. - Banco de Patentes
Back Nanomedicine for Combination Therapy Based on Cell Therapy and Nanomedicine.
Nanomedicine for Combination Therapy Based on Cell Therapy and Nanomedicine.
A new nanomedicine, with inhibitory activity on Rock kinase, for two therapeutic applications with high impact in human health: spinal cord injury and in metastatic breast cancer, alone or in combination with other approaches as a co-adjuvant in these treatments.
INDUSTRIAL PROPERTY RIGHTS
PCT / EP2020 / 058940 with title "POLYMERIC CONJUGATES AND THE USES OF THEM"
Co-owners: FCIPF and STEP BY STEP FOUNDATION
FURTHER INFORMATION
Quality of Life: Health Promotion and Efficient Health
CONTACT:
Centro de Investigación Príncipe Felipe (CIPF)
Eduardo Primo Yúfera, 3
46012 VALENCIA (Spain)
TEL: 96 328 96 80
Email: gerencia@cipf.es
Web: www.cipf.es